| Cat.No. | Name | Information |
|---|---|---|
| M2206 | TH-302 (Evofosfamide) | TH-302 is a highly potent and selective hypoxia-activated procompound targeting hypoxic regions of solid tumors with IC50 of 19 nM. |
| M6098 | Baicalein | Baicalein is a CYP2C9 and prolyl endopeptidase inhibitor, IC50 value of 3.12 mM. |
| M9325 | EGTA | EGTA is a specific calcium chelator with a Kd of 60.5 nM at physiological pH (7.4) and a high specificity for Ca2+ than for Mg2+.EGTA significantly inhibits the substrate adhesion capacity of inflammatory macrophages. |
| M9330 | Brij-35 | Brij-35 (Polidocanol) is a high HLB, ethoxylated, nonionic ether of lauryl alcohol with broad pH stability. |
| M6154 | 2-PMPA tetrasodium | 2-PMPA (PMPA tetrasodium salt) is a potent and selective inhibitor of glutamate carboxypeptidase II (GCPII) with an IC50 of 300 pM. |
| M2250 | Pamidronate disodium | Pamidronate disodium is a nitrogen containing bisphosphonate, used to the research of preventing osteoporosis. |
| M9916 | DPPH | DPPH (2,2-Diphenyl-1-picrylhydrazyl) is a stable free radical that measures the free radical scavenging activity of antioxidants. |
| M9194 | Insulin (human) | Insulin (human) is a polypeptide hormone that regulates the level of sugar (glucose) in the blood and is produced by beta cells of islets. |
| M3409 | Formestane | Formestane is a second generation selective aromatase inhibitor with an IC50 of 80 nM. |
| M9665 | N-(2-amino-2-oxoethyl)acrylamide | N-(2-Amino-2-oxoethyl)acrylamide |
| M21315 | lipid 10a | “lipid 10a” (Arcturus tunable lipid for RNA drug delivery). |
| M21311 | BAY 1214784 | BAY 1214784 is a potent, selective and orally active antagonist of the human gonadotropin-releasing hormone receptor (hGnRH-R).BAY 1214784 has the potential to be studied in uterine fibroids. |
| M21309 | 3-MORPHOLINOSYDNONIMINE | |
| M21302 | Narasin | Narasin is a cationic ion carrier and anticoccidial agent. narasin inhibits NF-κB signaling and induces apoptosis (tumor cell death), it has activity against gram-positive bacteria, anaerobic bacteria, mycoplasma and coccidia, and it also has antiviral effects. |
| M21301 | Pelacarsen | Pelacarsen (AKCEA-APO(a)-LRx) is a liver-specific, antisense oligonucleotide targeting apolipoprotein(a) that reduces lipoprotein(a) by 80% and is well tolerated. |
| M21300 | Luvadaxistat | Luvadaxistat (TAK-831) is a potential first-in-class D amino acid oxidase (DAAO) inhibitor that could be used in schizophrenia research. |
| M21297 | TP0586352 | TP0586352 is an LpxC inhibitor effective against carbapenem-resistant Klebsiella pneumoniae with no cardiovascular risk. |
| M21295 | PF07059013 | PF07059013 is a non-covalent oral hemoglobin (HbS) modulator. |
| M21294 | OI338 | OI338 is an oral, long-acting insulin analogue. |
| M21279 | MK-5204 | MK-5204 is a broad spectrum Candida antifungal agent derived from the natural product, enfumafungin. |
| M21269 | EC2629 | EC2629 is a folate receptor (FR)-targeting small molecule drug conjugate with a folate receptor-targeting molecule, a pyrrole-ring benzodiazepine (PBD) DNA cross-linked warhead and a linker. |
| M21268 | ETX0282 | ETX0282 is an oral prodrug of a class A, C and D serine beta-lactamase inhibitor in clinical development in combination with the beta-lactam drug cefpodoxime proxetil. |
| M21266 | MGS0274 | MGS0274 is a lipid-soluble precursor drug for the mGlu2 and mGlu3 receptor agonist MGS0008, which improves oral bioavailability. mGS0274 has potential for use in the study of schizophrenia. |
| M21263 | X-165 | X-165 is a clinical candidate compound for the study of autologous cell inhibitors in idiopathic pulmonary fibrosis, which was discovered through a 3-cycle DEL screen of 225M compounds obtained from amide coupling. |
| M21261 | Xeruborbactam | Xeruborbactam (QPX7728) is a potent, ultra-broad-spectrum inhibitor of boronic acid beta-lactamase. xeruborbactam inhibits serine and metallo-beta-lactamases in the nanomolar range. |
| M21258 | S6821 | S6821 is one of the two potent and selective TAS2R8 GPCR antagonists disclosed. |
| M21257 | MK-6884 | MK-6884 is an M4 muscarinic receptor orthomodulator (PAM) with a Ki value of 0.19 nM. MK-6884 is used in the study of neurodegenerative diseases. MK-6884 can be used as a positron emission computed tomography imaging agent with 11C radiolabeling. |
| M21256 | CD73-IN-2 | CD73-IN-2 is a potent CD73 inhibitor with an IC50 of 0.09 nM. |
| M21229 | BMS-986260 | BMS-986260 is a potent, selective, orally available TGFβR1 inhibitor with an IC50 of 1.6 nM. |
| M21219 | Maralixibat chloride | Maralixibat (SHP625) chloride is an orally active ileal bile acid transporter (IBAT) inhibitor. (IBAT) is used in the study of rare cholestatic liver diseases, including Alagille syndrome (ALGS), progressive familial intrahepatic cholestasis (PFIC), and biliary atresia. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
